Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;110:2673-2677
Published online before print August 16, 2004, doi: 10.1161/01.CIR.0000139842.15651.B2
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
110/17/2673    most recent
01.CIR.0000139842.15651.B2v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deb, A.
Right arrow Articles by Caplice, N. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deb, A.
Right arrow Articles by Caplice, N. M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Stem Cells
Related Collections
Right arrow Other Vascular biology
Right arrow Smooth muscle proliferation and differentiation

(Circulation. 2004;110:2673-2677.)
© 2004 American Heart Association, Inc.


Molecular Cardiology

Integrin Profile and In Vivo Homing of Human Smooth Muscle Progenitor Cells

Arjun Deb, MD*; Kimberly A. Skelding, MD*; Shaohua Wang, MD; Margo Reeder, BS; David Simper, MD; Noel M. Caplice, MD, PhD

From the Division of Cardiovascular Diseases and Molecular Medicine Program, Mayo Clinic, Rochester, Minn.

Correspondence to Noel M. Caplice MD, PhD, Mayo Clinic, GU 1801, 200 First St SW, Rochester, MN 55905. E-mail caplice.noel{at}mayo.edu

Received October 20, 2003; de novo received June 9, 2004; revision received June 23, 2004; accepted June 23, 2004.

Background— Recently, we identified circulating smooth muscle progenitor cells (SPCs) in human peripheral blood. The integrin profile of such progenitors is currently unknown and may affect their in vivo homing characteristics. In this study, we determined the integrin profile of vascular progenitors and SPC adhesion to extracellular matrix (ECM) proteins in vitro and in vivo.

Methods and Results— SPCs and endothelial progenitor cells (EPCs) were isolated from peripheral blood of healthy human subjects, and expression of surface integrins and adhesion to several vascular ECM proteins were determined. Homing of SPCs in vivo to specific ECM protein was determined by intracoronary infusion of fluorescent SPCs into porcine coronary arteries containing a fibronectin-coated mesh stent. SPCs had high expression of ß1 integrin, moderate expression of {alpha}1, low levels of {alpha}vß3, and did not express {alpha}vß5, ß2, {alpha}2ß1, or {alpha}4ß1 integrins. In contrast, EPCs had high expression of {alpha}2ß1, {alpha}vß3, {alpha}vß5, ß1, and {alpha}1 and minimal expression of {alpha}4ß1. Moreover, SPCs showed increased adherence to fibronectin and collagen type I compared with vitronectin, consistent with their integrin profile, and demonstrated a similar degree of in vivo attachment to fibronectin-coated mesh.

Conclusions— These data for the first time show a spectrum of integrin expression on vascular progenitors and suggest the potential importance of integrins in mediating adherence of SPCs to specific ECM both in vitro and in vivo.


Key Words: integrins • muscle, smooth • stem cells • extracellular matrix




This article has been cited by other articles:


Home page
Circ. Res.Home page
Q. Xu
Stem Cells and Transplant Arteriosclerosis
Circ. Res., May 9, 2008; 102(9): 1011 - 1024.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
T. J. Bunch, C. S. Rihal, R. J. Gumina, L. Cooper, and N. M. Caplice
Progression of Nonculprit Plaque Stenosis Following Successful Percutaneous Intervention
Angiology, May 1, 2008; 59(2): 236 - 239.
[Abstract] [PDF]


Home page
Stem CellsHome page
G. Ishii, T.-K. Ito, K. Aoyagi, H. Fujimoto, H. Chiba, T. Hasebe, S. Fujii, K. Nagai, H. Sasaki, and A. Ochiai
Presence of Human Circulating Progenitor Cells for Cancer Stromal Fibroblasts in the Blood of Lung Cancer Patients
Stem Cells, June 1, 2007; 25(6): 1469 - 1477.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Blindt, F. Vogt, I. Astafieva, C. Fach, M. Hristov, N. Krott, B. Seitz, A. Kapurniotu, C. Kwok, M. Dewor, et al.
A Novel Drug-Eluting Stent Coated With an Integrin-Binding Cyclic Arg-Gly-Asp Peptide Inhibits Neointimal Hyperplasia by Recruiting Endothelial Progenitor Cells
J. Am. Coll. Cardiol., May 2, 2006; 47(9): 1786 - 1795.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Sata
Role of Circulating Vascular Progenitors in Angiogenesis, Vascular Healing, and Pulmonary Hypertension: Lessons From Animal Models
Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 1008 - 1014.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. Roy-Chaudhury, V. P. Sukhatme, and A. K. Cheung
Hemodialysis Vascular Access Dysfunction: A Cellular and Molecular Viewpoint
J. Am. Soc. Nephrol., April 1, 2006; 17(4): 1112 - 1127.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
G. Qin, M. Ii, M. Silver, A. Wecker, E. Bord, H. Ma, M. Gavin, D. A. Goukassian, Y.-s. Yoon, T. Papayannopoulou, et al.
Functional disruption of {alpha}4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization
J. Exp. Med., January 23, 2006; 203(1): 153 - 163.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Zernecke, A. Schober, I. Bot, P. von Hundelshausen, E. A. Liehn, B. Mopps, M. Mericskay, P. Gierschik, E. A. Biessen, and C. Weber
SDF-1{alpha}/CXCR4 Axis Is Instrumental in Neointimal Hyperplasia and Recruitment of Smooth Muscle Progenitor Cells
Circ. Res., April 15, 2005; 96(7): 784 - 791.
[Abstract] [Full Text] [PDF]